![Mathias Skalmstad](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mathias Skalmstad
Director Financiero/CFO en
DIAMYD MEDICAL AB
.
Perfil
Mathias Skalmstad is currently Chief Financial Officer at Diamyd Medical AB since 2026.
Formerly, Chief Financial Officer at Sprint Bioscience AB from 2011 to 2023.
Education includes an undergraduate degree from Mälardalen University.
Cargos activos de Mathias Skalmstad
| Empresas | Cargo | Inicio |
|---|---|---|
| DIAMYD MEDICAL AB | Director Financiero/CFO | 01/07/2026 |
Antiguos cargos conocidos de Mathias Skalmstad.
| Empresas | Cargo | Fin |
|---|---|---|
| SPRINT BIOSCIENCE AB | Director Ejecutivo | - |
Formación de Mathias Skalmstad.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
10
Relaciones de 1er grado
3
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
Mälardalen University
 Mälardalen University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sprint Bioscience AB
 Sprint Bioscience AB Pharmaceuticals: MajorHealth Technology Develops medicines in the field of cancer and metabolism | Health Technology |
Diamyd Medical AB
 Diamyd Medical AB Pharmaceuticals: MajorHealth Technology Develops precision medicine drugs for type 1 diabetes and other forms of autoimmune diabetes | Health Technology |
- Bolsa de valores
- Insiders
- Mathias Skalmstad
